Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.97127 | 41 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.94989 | 41 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.95067 | 41 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.89929 | 41 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.87938 | 40 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.06656 | 42 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.01959 | 41 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.92553 | 41 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.91765 | 41 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.94425 | 42 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.94051 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.90069 | 41 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.94772 | 41 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.94805 | 41 |